Back to User profile » Prof. Dr. Lisong Teng

Papers published by Prof. Dr. Lisong Teng:


Preventative and Therapeutic Effects of Metformin in Gastric Cancer: A New Contribution of an Old Friend

Zhang J, Wen L, Zhou Q, He K, Teng L

Cancer Management and Research 2020, 12:8545-8554

Published Date: 16 September 2020

Prognostic Value of the Combination of CEA and Fibrinogen/Albumin Ratio in Resectable Gastric Cancer

Zhang J, Ruan J, Wang W, Lu Y, Wang H, Yu X, Wang H, Teng L

Cancer Management and Research 2020, 12:2767-2775

Published Date: 23 April 2020

The Ectopic Expression of SurvivinT34A and FilC Can Enhance the Oncolytic Effects of Vaccinia Virus in Murine Gastric Cancer

Wang M, Luo Y, Sun T, Mao C, Jiang Y, Yu X, Li Z, Xie T, Wu F, Yan H, Teng L

OncoTargets and Therapy 2020, 13:1011-1025

Published Date: 3 February 2020

HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer

Jiang X, Wu M, Xu Z, Wang H, Wang H, Yu X, Li Z, Teng L

Cancer Management and Research 2018, 10:6857-6867

Published Date: 12 December 2018

Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis

Su X, Jiang X, Wang W, Wang H, Xu X, Lin A, Teng X, Wu H, Teng L

OncoTargets and Therapy 2016, 9:6965-6976

Published Date: 11 November 2016

Diagnostic value of BRAFV600E-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis

Su X, Jiang X, Xu X, Wang W, Teng X, Shao A, Teng L

OncoTargets and Therapy 2016, 9:2495-2509

Published Date: 27 April 2016

Advances in the targeted therapy of liposarcoma

Guan Z, Yu X, Wang H, Wang H, Zhang J, Li G, Cao J, Teng L

OncoTargets and Therapy 2015, 8:125-136

Published Date: 5 January 2015

ER-α36: a novel biomarker and potential therapeutic target in breast cancer

Su XY, Xu X, Li GL, Lin BY, Cao J, Teng LS

OncoTargets and Therapy 2014, 7:1525-1533

Published Date: 30 August 2014